| Changes to trial information |
|
Section Name
|
Field Name
|
Date
|
Reason
|
Old Value
|
Updated Value
|
| Outcome |
OutCome List |
07/11/2025 |
POSTOPERATIVE |
Primary Outcome, the incidence of postoperative seroma..The presence of seroma was diagnosed clinically (by detection of a groin swelling ormass that has no impulse on cough) and confirmed by ultrasonography (Sac containing collection with no vascularity)., 30 days |
Primary Outcome, the incidence of postoperative seroma..The presence of seroma was diagnosed clinically (by detection of a groin swelling ormass that has no impulse on cough) and confirmed by ultrasonography (Sac containing collection with no vascularity)., 30 days POSTOPERATIVE |
|
Section Name
|
Field Name
|
Date
|
Reason
|
Old Value
|
Updated Value
|
| Outcome |
OutCome List |
08/11/2025 |
INDICATE POSTOPERATIVE DAYS |
Secondary Outcome, Pain (VAS score at 1, 10 and 30 days), incidence of complications (e.g., bleeding, infection, urinary retention), hernia recurrence within 30 days., 30 days |
Secondary Outcome, Pain (VAS score at 1, 10 and 30 days), incidence of complications (e.g., bleeding, infection, urinary retention), hernia recurrence within 30 days., 30 days POSTOPERATIVE |
|
Section Name
|
Field Name
|
Date
|
Reason
|
Old Value
|
Updated Value
|
| Reporting |
IPD description |
08/11/2025 |
response to reviewer |
Patient ID Group Age gender BMI Comorbidities Hernia side Hernia type Defect Size (cm) Plication Type of Mesh (Lightweight/Heavyweight) Mesh Fixation Duration of Surgery (min) Hospital Stay (days) Seroma at Post-op Day 2 Seroma at Day 10 Seroma at Day 30 Pain Score at Post-op Day 2 Pain Score at Day 10 Follow-up Pain Score at Day 30 Follow-up Chronic Pain at Month 3 (Yes/No) Hernia Recurrence at 30 Days (Yes/No) Post-op Complications Notes Preoperative Albumin (g/dL) Smoking Status (Yes/No) Diabetes Mellitus (Yes/No) Hypertension (Yes/No) Anticoagulant Use (Yes/No) Bilateral Hernia (Yes/No) Previous Groin Surgery (Yes/No) Hernia Size Type
|
The de-identified individual participant data (IPD) underlying the results reported in this study will be made available upon reasonable request to the corresponding author after publication. The data will include baseline characteristics, outcome measures, and adverse events. Access will be granted to researchers who provide a methodologically sound proposal and sign a data access agreement. |
|
Section Name
|
Field Name
|
Date
|
Reason
|
Old Value
|
Updated Value
|
| Eligibility |
Minimum age |
08/11/2025 |
correct as inclusion criteria more than 18 years |
18 Year(s) |
19 Year(s) |
|
Section Name
|
Field Name
|
Date
|
Reason
|
Old Value
|
Updated Value
|
| Reporting |
Result Summary Pdf file1 |
08/11/2025 |
uploaded a summary result overview containing Baseline characteristics, Participant flow (CONSORT flow diagram), Adverse events (if applicable) and Outcome measures |
38463_26773_1045.pdf |
38463_26773_1045.pdf |